Aliviane Methadone Clinic El Paso, TX - 79903

Aliviane Methadone Clinic is categorized under Drug Abuse and Addiction Treatment in El Paso, TX .

Aliviane Methadone Clinic was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Drug Abuse and Addiction Treatment business, which does work in the B2C market, and is classified as a Drug Abuse and Addiction Treatment, under code number 8133190 by the NAICS.

If you are seeking more information, feel free to contact Richard Overton, Administrator at the company’s single location by writing to 1900 Wyoming Avenue, El Paso, Texas TX 79903 or by phoning (915) 779-4527. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Aliviane Methadone Clinic
Contact Person: Richard Overton, Administrator
Address: 1900 Wyoming Avenue, El Paso, Texas 79903
Phone Number: (915) 779-4527
Website Address: aliviane.org
Annual Revenue (USD): Unknown
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Drug Abuse and Addiction Treatment
SIC Code: 8399
NAICS Code: 8133190
Share This Business:

Aliviane Methadone Clinic was started in 0 to provide professional Drug Abuse and Addiction Treatment under the SIC code 8399 and NAICS code 8133190. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Richard Overton, Administrator for inquiries that concern Aliviane Methadone Clinic by calling the company number (915) 779-4527, as your correspondence is most welcome. Additionally, the physical location of the single location of Aliviane Methadone Clinic can be found at the coordinates 31.77393,-106.47239 as well as the street address 1900 Wyoming Avenue in El Paso, Texas 79903.

For its online presence, you may visit Aliviane Methadone Clinic’s website at aliviane.org and engage with its social media outlets through on Twitter and on Facebook.